These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23531849)

  • 1. Value of podoplanin as an immunohistochemical marker in tumor diagnosis: a review and update.
    Ordóñez NG
    Appl Immunohistochem Mol Morphol; 2014; 22(5):331-47. PubMed ID: 23531849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podoplanin is Positive Not Only on Follicular Dendritic Cells and Their Tumoral Counterparts, But Also on Reticular Fibroblasts and in Some Tumors of Reticular Fibroblasts.
    Suárez-Vilela D; Izquierdo FM
    Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):e11. PubMed ID: 25493707
    [No Abstract]   [Full Text] [Related]  

  • 3. Podoplanin: a novel diagnostic immunohistochemical marker.
    Ordóñez NG
    Adv Anat Pathol; 2006 Mar; 13(2):83-8. PubMed ID: 16670463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
    Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D
    Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
    Ordóñez NG
    Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podoplanin as a marker for mesothelioma.
    Kimura N; Kimura I
    Pathol Int; 2005 Feb; 55(2):83-6. PubMed ID: 15693854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of podoplanin expression in esophageal squamous cell carcinoma: a retrospective study.
    Tong L; Yuan S; Feng F; Zhang H
    Dis Esophagus; 2012 Jan; 25(1):72-80. PubMed ID: 21895849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.
    Schacht V; Dadras SS; Johnson LA; Jackson DG; Hong YK; Detmar M
    Am J Pathol; 2005 Mar; 166(3):913-21. PubMed ID: 15743802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
    Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
    Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-negative, basal marker-expressing, and high-grade breast carcinomas are characterized by high lymphatic vessel density and the expression of podoplanin in stromal fibroblasts.
    Niemiec JA; Adamczyk A; Ambicka A; Mucha-Małecka A; M Wysocki W; Ryś J
    Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):10-6. PubMed ID: 23455186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study.
    Margaritescu C; Raica M; Pirici D; Simionescu C; Mogoanta L; Stinga AC; Stinga AS; Ribatti D
    Histol Histopathol; 2010 Jun; 25(6):701-11. PubMed ID: 20376776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of calretinin immunostaining in diagnostic pathology: a review and update.
    Ordóñez NG
    Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):401-15. PubMed ID: 24185118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podoplanin, a novel marker for seminoma: A comparison study evaluating immunohistochemical expression of podoplanin and OCT3/4.
    Idrees M; Saxena R; Cheng L; Ulbright TM; Badve S
    Ann Diagn Pathol; 2010 Oct; 14(5):331-6. PubMed ID: 20850695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the lymphatic marker podoplanin (D2-40) in human fetal eyes.
    Herwig MC; Münstermann K; Klarmann-Schulz U; Schlereth SL; Heindl LM; Loeffler KU; Müller AM
    Exp Eye Res; 2014 Oct; 127():243-51. PubMed ID: 25135789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic vessel density and lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Horvath LG; Sutherland RL; Williams ED
    Prostate; 2005 Nov; 65(3):222-30. PubMed ID: 15948136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated podoplanin staining in breast myoepithelial cells: a potential caveat in the diagnosis of lymphatic invasion.
    Yang Z; Adams AL; Hameed O
    Appl Immunohistochem Mol Morphol; 2009 Oct; 17(5):425-30. PubMed ID: 19363443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma].
    Breiteneder-Geleff S; Soleiman A; Horvat R; Amann G; Kowalski H; Kerjaschki D
    Verh Dtsch Ges Pathol; 1999; 83():270-5. PubMed ID: 10714221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual role of podoplanin in oral cancer development.
    Cîrligeriu L; Cimpean AM; Raica M; Doroş CI
    In Vivo; 2014; 28(3):341-7. PubMed ID: 24815836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD9 expression on lymphatic vessels in head and neck mucosa.
    Erovic BM; Neuchrist C; Kandutsch S; Woegerbauer M; Pammer J
    Mod Pathol; 2003 Oct; 16(10):1028-34. PubMed ID: 14559986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin is a useful marker for identifying mesothelioma in malignant effusions.
    Hanna A; Pang Y; Bedrossian CW; Dejmek A; Michael CW
    Diagn Cytopathol; 2010 Apr; 38(4):264-9. PubMed ID: 20146302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.